Sysmex Corp (6869):企業の財務・戦略的SWOT分析

◆英語タイトル:Sysmex Corp (6869) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C7704
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:65
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Sysmex Corp (6869) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sysmex Corp (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory information systems to clinical laboratories for testing. The solutions that the company offers include heamatology, hemostasis, urinalysis analyzers. It conducts research and development at its facilities in Japan, North America and Europe. The company operates along with its subsidiaries in the Americas, Europe, Middle East, Africa and Asia Pacific. Its products are used by medical institutions. Sysmex is headquartered in Hyogo, Japan.

Sysmex Corp Key Recent Developments

Sep 28,2018 Sysmex Inostics Announces Launch of OncoBEAMTM EGFR Kit v2 RUO in Europe and Asia
Sep 28,2018 Sysmex Inostics Announces Launch of OncoBEAMTM EGFR Kit v2 RUO in Europe and Asia
Sep 05,2018 2018 Veeva R&D summit to showcase advances for speeding product development
Aug 16,2018 Sysmex America opens “Center for Learning,” expanding training facilities for customers in North America

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Sysmex Corp – Key Facts 6
Sysmex Corp – Key Employees 7
Sysmex Corp – Key Employee Biographies 8
Sysmex Corp – Major Products and Services 9
Sysmex Corp – History 10
Sysmex Corp – Company Statement 17
Sysmex Corp – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Joint Venture 21
Section 2 – Company Analysis 22
Company Overview 22
Sysmex Corp – Business Description 23
Business Segment: Instruments 23
Overview 23
Performance 23
Business Segment: Maintenance services 24
Overview 24
Performance 24
Business Segment: Others 24
Performance 24
Business Segment: Reagents 24
Overview 24
Performance 24
Geographical Segment: Americas 24
Performance 24
Geographical Segment: Asia Pacific 24
Performance 24
Geographical Segment: China 25
Performance 25
Geographical Segment: EMEA 25
Performance 25
Geographical Segment: Japan 25
Performance 25
R&D Overview 25
Sysmex Corp – Corporate Strategy 26
Sysmex Corp – SWOT Analysis 27
SWOT Analysis – Overview 27
Sysmex Corp – Strengths 27
Sysmex Corp – Weaknesses 28
Sysmex Corp – Opportunities 29
Sysmex Corp – Threats 30
Sysmex Corp – Key Competitors 31
Section 3 – Company Financial Ratios 32
Financial Ratios – Capital Market Ratios 32
Financial Ratios – Annual Ratios 33
Performance Chart 36
Financial Performance 36
Financial Ratios – Interim Ratios 37
Financial Ratios – Ratio Charts 38
Section 4 – Company’s Lifesciences Financial Deals and Alliances 39
Sysmex Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 39
Sysmex Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018 40
Sysmex Corp, Recent Deals Summary 41
Section 5 – Company’s Recent Developments 42
Oct 02, 2018: In Vitro Diagnostics Company Sysmex Europe Announces Executive Leadership Change 42
Aug 16, 2018: Sysmex America opens “Center for Learning,” expanding training facilities for customers in North America 43
Aug 03, 2018: Sysmex: Summary of consolidated financial results for the first three months of the fiscal year ending March 31, 2019 45
Aug 03, 2018: Sysmex and JVCKENWOOD jointly establish company to use micro and nano-fabrication technology to develop and manufacture IVD Biodevices 50
Jul 10, 2018: Sysmex Establishes Subsidiary in Egypt and Begins Conducting Direct Sales and Services 52
Jul 02, 2018: OGT expands direct sales and support infrastructure in Europe 53
May 31, 2018: Clinical Evaluation of Sysmex Inostics’ Plasma NGS Liquid Biopsy Technology to Complement Mammography When Screening for Early Stage Breast Cancer Presented at the 2018 ASCO Annual Meeting 54
May 09, 2018: Sysmex Announces Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2018 55
May 09, 2018: Sysmex Group Formulates New Long-Term Management Goals 58
May 08, 2018: Sysmex to Establish Bio-Diagnostic Reagent Center 60
Section 6 – Appendix 61
Methodology 61
Ratio Definitions 61
About GlobalData 65
Contact Us 65
Disclaimer 65

List of Tables
Sysmex Corp, Key Facts 6
Sysmex Corp, Key Employees 7
Sysmex Corp, Key Employee Biographies 8
Sysmex Corp, Major Products and Services 9
Sysmex Corp, History 10
Sysmex Corp, Other Locations 18
Sysmex Corp, Subsidiaries 19
Sysmex Corp, Joint Venture 21
Sysmex Corp, Key Competitors 31
Sysmex Corp, Ratios based on current share price 32
Sysmex Corp, Annual Ratios 33
Sysmex Corp, Annual Ratios (Cont...1) 34
Sysmex Corp, Annual Ratios (Cont...2) 35
Sysmex Corp, Interim Ratios 37
Sysmex Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 39
Sysmex Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018 40
Sysmex Corp, Recent Deals Summary 41
Currency Codes 61
Capital Market Ratios 61
Equity Ratios 62
Profitability Ratios 62
Cost Ratios 63
Liquidity Ratios 63
Leverage Ratios 64
Efficiency Ratios 64

List of Figures
Sysmex Corp, Performance Chart (2014 - 2018) 36
Sysmex Corp, Ratio Charts 38
Sysmex Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 39
Sysmex Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 40

★海外企業調査レポート[Sysmex Corp (6869):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sunnybrook Research Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Sunnybrook Research Institute (SRI) an educational institute that offers medical education and research services. The institute provides undergraduate, postgraduate and doctoral degree programs. It provides research platforms for biological sciences, evaluative clinical sciences and physical …
  • Autoridad del Canal de Panama:企業の戦略的SWOT分析
    Autoridad del Canal de Panama - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • British Land Company plc:企業のM&A・事業提携・投資動向
    British Land Company plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's British Land Company plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • AECOM :企業の戦略・SWOT・財務情報
    AECOM - Strategy, SWOT and Corporate Finance Report Summary AECOM - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • Dentsu International Ltd:企業の戦略的SWOT分析
    Dentsu International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • NuVasive Inc (NUVA):企業の財務・戦略的SWOT分析
    NuVasive Inc (NUVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Tasly Pharmaceutical Group Co Ltd (600535):企業の財務・戦略的SWOT分析
    Tasly Pharmaceutical Group Co Ltd (600535) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Itausa – Investimentos Itau S.A.:企業の戦略・SWOT・財務情報
    Itausa - Investimentos Itau S.A. - Strategy, SWOT and Corporate Finance Report Summary Itausa - Investimentos Itau S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Cyxone AB-製薬・医療分野:企業M&A・提携分析
    Summary Cyxone AB (Cyxone) is a biopharmaceutical company that develops cyclotide drugs for immune-related diseases. The company’s lead product include T20K, a compound to inhibit pro-inflammatory cytokines, such as IL2 that helps to reduce clinical symptoms in an animal model for multiple sclerosis …
  • BBA Aviation plc (BBA):企業の財務・戦略的SWOT分析
    BBA Aviation plc (BBA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Royal Orchid Hotels Ltd:企業の戦略・SWOT・財務分析
    Royal Orchid Hotels Ltd - Strategy, SWOT and Corporate Finance Report Summary Royal Orchid Hotels Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Econet Wireless Zimbabwe Ltd:企業の戦略・SWOT・財務分析
    Econet Wireless Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report Summary Econet Wireless Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Ponti’s Group Limited:企業の戦略・SWOT・財務情報
    Ponti's Group Limited - Strategy, SWOT and Corporate Finance Report Summary Ponti's Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • CAS Medical Systems Inc (CASM):医療機器:M&Aディール及び事業提携情報
    Summary CAS Medical Systems Inc (CASMED) is a medical device company that designs, manufactures and markets technologies and monitors. The company offers technologies and monitors that deliver patient data. Its products comprise FORE-SIGHT absolute tissue oximeter, blood pressure measurement technol …
  • PsiOxus Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary PsiOxus Therapeutics Ltd (PsiOxus), formerly known as Myotec Therapeutics Ltd, is a drug company that develops novel therapeutics for cancer and other clinically unmet diseases. The company's pipeline product portfolio includes an oncolytic vaccine and a dual action anabolic catabolic transf …
  • Athenex Inc (ATNX):製薬・医療:M&Aディール及び事業提携情報
    Summary Athenex Inc (Athenex), formerly Kinex Pharmaceuticals LLC, is a biopharmaceutical company focused on the discovery, development and commercialization novel medicines and cell therapies for the treatment of cancers. The company’s orascovery products candidates include oral formulations of pac …
  • ValiRx Plc (VAL)-医療機器分野:企業M&A・提携分析
    Summary ValiRx Plc (ValiRx) is a biopharmaceutical company that develops technologies and therapeutic options for the treatment of cancer. The company’s products and technology include GeneICE-silencing rebellious genes, GeneICE – BCL-2, VAL201-prostate cancer, NAV3 cancer screening test and VAL401- …
  • Oakton Limited:企業の戦略的SWOT分析
    Oakton Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • bioMerieux SA.:企業の戦略・SWOT・財務分析
    bioMerieux SA. - Strategy, SWOT and Corporate Finance Report Summary bioMerieux SA. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Aviragen Therapeutics Inc (AVIR)-製薬・医療分野:企業M&A・提携分析
    Summary Aviragen Therapeutics Inc (Aviragen) is a pharmaceutical company that carries out anti-infective drug discovery, development and its commercialization to treat respiratory diseases. It has four product candidates in clinical development which address viral infections, namely, vapendavir, ora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆